<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Of all laboratory-confirmed cases during 2010–2016, there were 13,882 mild cases, 2886 severe cases and 64 deaths. The positive rates of EV-A71, CV-A16 and other EVs in mild cases were 36.62%, 23.71% and 39.67%, respectively. In severe cases, the positive rate of EV-A71 was 65.70%, while CV-A16 and other EVs were 6.27% and 28.03% respectively. Furthermore, the positive rate of EV-A71 reached 98.43% in all the deaths except 1 cases of other EVs infection (Fig. 
 <xref rid="Fig4" ref-type="fig">4</xref>). There was significant difference in the proportion of pathogens in different case types. EV-A71 was more frequently detected in deaths and severe cases than in mild cases, while CV-A16 was more frequently detected in mild cases than in severe cases, no CV-A16 was detected in deaths.
</p>
